Newron Pharmaceuticals S.p.A. (NP5.DE)
EUR 8.8
(-0.34%)
EUR 8.8
(-0.34%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -10.6 Million | -11.09 Million | -11.44 Million | -15.58 Million | -22.21 Million | -16.1 Million |
| Net Income | -16.96 Million | -17.47 Million | -14.88 Million | -19.61 Million | -20.16 Million | -15.01 Million |
| Depreciation & Amortization | 210.14 Thousand | 202 Thousand | 209 Thousand | 219 Thousand | 206 Thousand | 47 Thousand |
| Deferred income taxes | 2.45 Million | - | - | - | -5.11 Million | - |
| Stock-based compensation | 197 Thousand | 480 Thousand | 762 Thousand | 1.46 Million | 2.12 Million | 2.1 Million |
| Change in working capital | 1.58 Million | 2 Million | -96 Thousand | 3.73 Million | 562 Thousand | 1.79 Million |
| Other non-cash items | 1.91 Million | 3.69 Million | 2.56 Million | -1.38 Million | 170 Thousand | -5.04 Million |
| Investing Cash Flow | 3.39 Million | -317 Thousand | 8.42 Million | -616 Thousand | -932 Thousand | 3.03 Million |
| Investments in PPE | -11.5 Thousand | -18 Thousand | -20 Thousand | -35 Thousand | -51 Thousand | -40 Thousand |
| Acquisitions | - | 299 Thousand | -8.44 Million | 1000.00 | 881 Thousand | - |
| Investment purchases | -1.02 Million | -3.04 Million | -1.69 Million | -2.21 Million | -3.05 Million | - |
| Sales/Maturities of investments | 4.43 Million | 2.74 Million | 10.13 Million | 1.63 Million | 2.17 Million | 3 Million |
| Other Investing Activities | -1.00 | -299 Thousand | 8.44 Million | -1000.00 | -881 Thousand | 76 Thousand |
| Financing Cash Flow | -200.73 Thousand | -186 Thousand | 14.83 Million | 7.36 Million | 17.57 Million | 51 Thousand |
| Debt repayment | -192 Thousand | -186 Thousand | -15.63 Million | -7.41 Million | -17.9 Million | -154 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | 51 Thousand |
| Other Financing Activities | -192 Thousand | -186 Thousand | 30.46 Million | 14.78 Million | 35.47 Million | 127 Thousand |
| Accounts receivables | 2.47 Million | -894.52 Thousand | 1.82 Million | 1.21 Million | -161.68 Thousand | 3.06 Million |
| Accounts payables | 603.24 Thousand | 585.19 Thousand | -4.11 Million | 551.04 Thousand | 723.46 Thousand | -1.22 Million |
| Inventory | - | 88.22 Thousand | 179.11 Thousand | 46.79 Thousand | 12.49 Thousand | 5122.72 |
| Other working capital | -1.49 Million | 2.22 Million | 2.01 Million | 1.91 Million | -12.27 Thousand | -51.27 Thousand |
| Cash at beginning of period | 13.39 Million | 25.01 Million | 13.21 Million | 22.05 Million | 27.62 Million | 40.64 Million |
| Cash at end of period | 6.34 Million | 13.42 Million | 25.01 Million | 13.21 Million | 22.05 Million | 27.62 Million |
| Capital Expenditure | -11.5 Thousand | -18 Thousand | -20 Thousand | -35 Thousand | -51 Thousand | -40 Thousand |
| Effect of forex changes on cash | 356.17 Thousand | - | - | - | - | - |
| Net cash flow / Change in cash | -7.05 Million | -11.59 Million | 11.8 Million | -8.83 Million | -5.57 Million | -13.01 Million |
| Free Cash Flow | -10.61 Million | -11.11 Million | -11.46 Million | -15.62 Million | -22.26 Million | -16.14 Million |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -9.55 Million | -16.96 Million | -9.27 Million | -7.01 Million | -17.47 Million | -8.75 Million |
| Depreciation & Amortization | 96 Thousand | 210.14 Thousand | 99 Thousand | 102.91 Thousand | 202 Thousand | 101.8 Thousand |
| Deferred income taxes | - | 2.45 Million | 5.85 Million | -3.27 Million | - | 488.7 Thousand |
| Stock-based compensation | 170 Thousand | 197 Thousand | 142 Thousand | 55 Thousand | 480 Thousand | 130 Thousand |
| Change in working capital | 468 Thousand | 1.58 Million | 958 Thousand | -1.61 Million | 2 Million | 1.68 Million |
| Other non-cash items | -5000.00 | 1.91 Million | 3.53 Million | 6.09 Million | 3.69 Million | 1.25 Million |
| Investing Cash Flow | 2 Million | 3.39 Million | 3.25 Million | -11.09 Thousand | -317 Thousand | 118.25 Thousand |
| Investments in PPE | -7000.00 | -11.5 Thousand | -3000.00 | -8072.06 | -18 Thousand | -8409.08 |
| Acquisitions | - | - | -3.25 Million | 3000.06 | 299 Thousand | -106 Thousand |
| Investment purchases | -442.36 Thousand | -1.02 Million | -584.59 Thousand | -405.62 Thousand | -3.04 Million | -1.32 Million |
| Sales/Maturities of investments | 2.45 Million | 4.43 Million | 3.94 Million | 402.59 Thousand | 2.74 Million | 1.44 Million |
| Other Investing Activities | 2.01 Million | -1.00 | 3.26 Million | -3000.00 | -299 Thousand | 106 Thousand |
| Financing Cash Flow | 8.37 Million | -200.73 Thousand | -95 Thousand | -97.87 Thousand | -186 Thousand | -87.93 Thousand |
| Debt repayment | -97 Thousand | -192 Thousand | - | -97 Thousand | -186 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 8.46 Million | - | - | - | - | - |
| Other Financing Activities | 8.47 Million | - | -95 Thousand | - | -186 Thousand | -94 Thousand |
| Accounts receivables | -826 Thousand | 2.47 Million | 109 Thousand | -1.42 Million | -894.52 Thousand | -230.65 Thousand |
| Accounts payables | -1.53 Million | 603.24 Thousand | 2.26 Million | -1.58 Million | 585.19 Thousand | 1.05 Million |
| Inventory | - | - | -1.00 | - | 88.22 Thousand | - |
| Other working capital | 1.29 Million | -1.49 Million | 849 Thousand | 1.4 Million | 2.22 Million | 861.52 Thousand |
| Cash at beginning of period | 6.34 Million | 13.39 Million | 7.71 Million | 13.39 Million | 25.01 Million | 18.86 Million |
| Cash at end of period | 7.89 Million | 6.34 Million | 6.34 Million | 7.7 Million | 13.42 Million | 13.39 Million |
| Capital Expenditure | -7000.00 | -11.5 Thousand | -3000.00 | -8072.06 | -18 Thousand | -8409.08 |
| Effect of forex changes on cash | - | 356.17 Thousand | -121.07 Thousand | 76.78 Thousand | - | -402.94 Thousand |
| Net cash flow / Change in cash | 1.55 Million | -7.05 Million | -1.37 Million | -5.68 Million | -11.59 Million | -5.46 Million |
| Free Cash Flow | -8.83 Million | -10.61 Million | -4.54 Million | -5.66 Million | -11.11 Million | -5.1 Million |
EAX
MEE
EKI
BNZIW
KABRAEXTRU
CTTH